Search hospitals
>
Oregon
>
Portland
Providence Portland Medical Center
Claim this profile
Portland, Oregon 97213
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Melanoma
578 reported clinical trials
37 medical researchers
Summary
Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 575 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Area of expertise
Lung Cancer
Providence Portland Medical Center has run 121 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Providence Portland Medical Center has run 95 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Alison K. Conlin
Providence Portland Medical Center
7 years of reported clinical research
Charles W. Drescher
Providence Portland Medical Center
9 years of reported clinical research
Rachel Sanborn, MD
Providence Portland Medical Center
6 years of reported clinical research
Nitya Alluri
Providence Portland Medical Center
2 years of reported clinical research
Clinical Trials running at Providence Portland Medical Center
Lung Cancer
Breast Cancer
Breast cancer
Cancer
Ovarian Cancer
Prostate Cancer
Cervical Cancer
Bladder Cancer
Esophageal cancer
Esophageal Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting
2 awards
Phase 3
27 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting
2 awards
Phase 3
8 criteria
Radiation Therapy
for Brain Metastasis
This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting
2 awards
Phase 3
12 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Providence Portland Medical Center?
Providence Portland Medical Center is a medical facility located in Portland, Oregon. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Non-Small Cell Lung Cancer, Melanoma and other specialties. Providence Portland Medical Center is involved with conducting 578 clinical trials across 575 conditions. There are 37 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Rachel Sanborn, MD, and Nitya Alluri.
Where is Providence Portland Medical Center located?
**Providence Portland Medical Center** - **Address:** 4805 NE Glisan St, Portland, OR 97213 - **Accessibility:** Easily accessible via public transit, including bus and light rail options. - **Specialties:** Renowned for excellence in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health.
Who should I call to ask about financial aid or insurance network?
For financial assistance at Providence Portland Medical Center: - Contact financial counselors at **855-229-6466**, available Monday – Friday, 7 a.m. to 5:30 p.m. PT. - For billing inquiries related to Providence Hospitals & Clinics, call **866-747-2455** (toll-free) or **503-574-5791** (local - Portland metro area). - For billing inquiries related to Providence Health Plan, call **800-878-4445** (toll-free) or **503-574-5791** (local - Portland metro area).
What insurance does Providence Portland Medical Center accept?
Providence Portland Medical Center accepts a wide range of health plans, including Aetna, Blue Cross Blue Shield, Cigna, Coventry, First Health, Humana, MultiPlan, Private Healthcare Systems (PHCS), TRICARE for Life, United Healthcare, and more. The hospital also accepts various Medicare and Medicaid plans, alongside commercial/indemnity insurance plans. For the most accurate information regarding coverage, please check directly with your insurance provider and the hospital.
What awards or recognition has Providence Portland Medical Center received?
Providence Portland Medical Center, located in Portland, Oregon, has been awarded a Health Care Innovation Award of $17,337,093 for transforming the delivery system of Oregon's largest Medicaid Coordinated Care Organization (CCO). This initiative focuses on enhancing care coordination, quality, and outcomes for high-cost, high-acuity Medicaid patients while aiming to reduce overall health care costs. The hospital is renowned for its excellence in patient care and research, particularly in cancer, heart, orthopedics, women's health, rehabilitation services, and behavioral health, and holds the prestigious Magnet® designation for nursing excellence.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.